MedTrace Logo

Point-of-Care System for Determination of Bilirubin Capacity in Neonates

NCT02612207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161

Last updated 2021-09-28

No results posted yet for this study

Summary

The aims of this observational bench project are to validate the performance of the miniaturized and modernized hematofluorometer that measures bilirubin capacity into a product and is suitable for operation in various point of care environments w in the management of preterm neonates.

Conditions

  • Jaundice, Neonatal
  • Hyperbilirubinemia
  • Bilirubin-Induced Neurological Dysfunction (BIND)

Interventions

DEVICE

Bilirubin Binding Capacity by Hematofluorometry Validation

Observation study

Sponsors & Collaborators

Principal Investigators

  • Vinod K Bhutani, MD · PI

Eligibility

Min Age
6 Hours
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612207 on ClinicalTrials.gov